Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / BPIFA1

BPIFA1

Basics

Aliases:
This biomarker is also known as:
  • SPLUNC1,
  • Secretory Protein In Upper Respiratory Tracts,
  • Nasopharyngeal Carcinoma-Related Protein,
  • Ligand-Binding Protein RYA3,
  • Lung-Specific Protein X,
  • NASG,
  • Palate Lung And Nasal Epithelium Clone Protein,
  • SPURT,
  • Palate, Lung And Nasal Epithelium Associated,
  • Protein Plunc,
  • PLUNC,
  • Palate, Lung And Nasal Epithelium Carcinoma Associated,
  • BPI Fold Containing Family A, Member 1,
  • LUNX,
  • Tracheal Epithelium-Enriched Protein,
  • BPI Fold-Containing Family A Member 1,
  • Von Ebner Protein Hl,
  • Tracheal Epithelium Enriched Protein,
  • BA49G10.5,

View in BioMuta

Description…

The BPIFA1 gene was formerly known as PLUNC. This human gene is the homolog of murine Plunc, and shows the same expression pattern as murine Plunc. Both are expressed in the upper airways and nasopharyngeal regions. Human BPIFA1 may be involved in the airway inflammatory response after exposure to irritants and may be associated with tumor progression. BPIFA1 may also play a role in innate immune responses of the upper airways. And it may serve as a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Multiple transcript variants resulting from alternative splicing in the 3' UTR have been detected, but only three full length variants have been isolated.

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: BPIFA1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.